NORDIC BIOTECH K/S

Past relations

Ultimate beneficial owners (UBOs): Florian Schønharting
2017-11-28 –
Legal owners: Foundation Asset Management AB
2015-03-26 – 10% ownership (2015-03-26 – ) 10% voting rights (2015-03-26 – )

NORDIC BIOTECH GENERAL PARTNER ApS

LUNDBECKFOND INVEST A/S 10% ownership (2015-04-13 – ) 10% voting rights (2015-04-13 – )

Danmarks Eksport- og Investeringsfond 10% ownership (2023-04-01 – ) 10% voting rights (2023-04-01 – )

BVF/Nexgen Investments, L.P.
2002-07-31 – 25% ownership (2002-07-31 – ) 25% voting rights (2002-07-31 – )

European Investment Fund
2002-07-31 – 25% ownership (2002-07-31 – ) 25% voting rights (2002-07-31 – )

HBM Healthcare Investments (Cayman) Ltd
2002-07-31 – 5% ownership (2002-07-31 – ) 5% voting rights (2002-07-31 – )

VÆKSTFONDEN 10% ownership (2002-07-31 – 2023-03-31 ) 10% voting rights (2002-07-31 – 2023-03-31 )
Directors: NORDIC BIOTECH GENERAL PARTNER ApS
Board members: Claus Tycho Bræstrup
2002-06-20 – 2002-06-20

Lars Grønborg Eskesen
2002-06-20 – 2002-06-20

Maja Kirstine Elsøe
2002-06-20 – 2002-06-20

Matthew Daniel Perry
2002-06-20 – 2002-06-20
Subsidiaries: Holdingselskabet af 1 januar 2016 ApS 33.33% ownership (2017-03-14 – 2017-10-04 ) 33.33% voting rights (2017-03-14 – 2017-10-04 )

Revenue

Profit/loss

'000	12-2012	12-2013	12-2014	12-2015	12-2016	12-2017
Currency	DKK	DKK	DKK	DKK	DKK	DKK
Revenue	0	0	0	0	0	0
Raw materials and consumables used	0	0	0	0	0	0
Other external expenses	3,665	2,836	44	212	0	0
Gross profit loss	0	-2,836	-44	0	0	0
Employee benefits expense	0	0	0	0	0	0
Wages and salaries	0	0	0	0	0	0
Depreciation amortisation expense and impairment losses of prop	0	0	0	0	0	0
Profit loss from ordinary operating activities	554,360	293,509	2,030,926	0	0	149,666
Profit loss from ordinary activities before tax	0	0	0	0	0	0
Other finance expenses	0	0	0	0	0	0
Tax expense	0	0	0	0	0	0
Profit loss	571,212	302,522	2,030,926	317,378	-1,098,813	149,646